Hill-Rom Holdings ROA 2006-2018 | HRC

Current and historical return on assets (ROA) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Hill-Rom Holdings ROA for the three months ending June 30, 2018 was 6.69%.
Hill-Rom Holdings Annual ROA
2017 2.92
2016 2.88
2015 1.05
2014 3.46
2013 6.62
2012 7.42
2011 10.28
2010 10.12
2009 -32.86
2008 3.97
2007 3.33
2006 4.02
2005 -4.32
Hill-Rom Holdings Quarterly ROA
Q3 2018 1.01
Q2 2018 0.63
Q1 2017 1.98
Q4 2017 1.53
Q3 2017 0.13
Q2 2017 0.76
Q1 2016 0.57
Q4 2016 1.21
Q3 2016 1.06
Q2 2016 0.52
Q1 2015 0.10
Q4 2015 -0.23
Q3 2015 1.06
Q2 2015 1.53
Q1 2014 0.70
Q4 2014 1.41
Q3 2014 1.76
Q2 2014 -0.22
Q1 2013 0.86
Q4 2013 2.23
Q3 2013 1.51
Q2 2013 1.42
Q1 2012 1.49
Q4 2012 2.41
Q3 2012 1.80
Q2 2012 1.96
Q1 2011 2.69
Q4 2011 4.89
Q3 2011 0.12
Q2 2011 2.58
Q1 2010 2.89
Q4 2010 4.08
Q3 2010 2.50
Q2 2010 2.01
Q1 2009 1.66
Q4 2009 2.14
Q3 2009 1.73
Q2 2009 -39.75
Q1 2008 0.87
Q4 2008 1.41
Q3 2008 1.34
Q2 2008 0.57
Q1 2007 0.57
Q4 2007 2.27
Q3 2007 0.55
Q2 2007 0.77
Q1 2006 2.59
Q4 2006 3.45
Q3 2006 2.33
Q2 2006 2.56
Q1 2005 2.15
Q4 2005 -10.37
Q3 2005 1.89
Q2 2005 2.61
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.093B $2.744B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $131.648B 20.18
Abbott Laboratories (ABT) United States $120.680B 25.29
Stryker (SYK) United States $64.884B 25.07
Boston Scientific (BSX) United States $52.302B 27.21
Baxter (BAX) United States $41.507B 28.25
Zimmer Biomet Holdings (ZBH) United States $26.600B 17.09
Smith & Nephew SNATS (SNN) United Kingdom $16.217B 0.00
ResMed (RMD) United States $16.192B 32.15
Canopy Growth (CGC) Canada $11.975B 0.00
Perrigo (PRGO) Ireland $10.112B 14.35
Bio-Rad Laboratories (BIO) United States $8.981B 57.67
Insulet (PODD) United States $6.053B 0.00
Haemonetics (HAE) United States $5.742B 52.40
ICU Medical (ICUI) United States $5.439B 36.86
GW Pharmaceuticals (GWPH) United Kingdom $4.724B 0.00
Neogen (NEOG) United States $4.687B 74.58
Agios Pharmaceuticals (AGIO) United States $4.290B 0.00
Hutchison China MediTech (HCM) China $3.830B 0.00
NuVasive (NUVA) United States $3.571B 33.87
National Vision Holdings (EYE) United States $3.297B 72.82
Quidel (QDEL) United States $2.670B 54.71
NxStage Medical (NXTM) United States $1.856B 0.00
Phibro Animal Health (PAHC) United States $1.754B 24.97
Cardiovascular Systems (CSII) United States $1.262B 753.60
AtriCure (ATRC) United States $1.258B 0.00
Omeros (OMER) United States $1.180B 0.00
VAREX IMAGING (VREX) United States $1.150B 18.79
Owens & Minor (OMI) United States $1.075B 11.50
PetIQ (PETQ) United States $1.059B 34.63
Eagle Pharmaceuticals (EGRX) United States $1.039B 30.67
Cerus (CERS) United States $0.988B 0.00
Surmodics (SRDX) United States $0.972B 117.42
MacroGenics (MGNX) United States $0.958B 0.00
OraSure Technologies (OSUR) United States $0.946B 61.84
TG Therapeutics (TGTX) United States $0.750B 0.00
Insys Therapeutics (INSY) United States $0.702B 0.00
LeMaitre Vascular (LMAT) United States $0.662B 31.76
Meridian Bioscience (VIVO) United States $0.642B 21.96
Lantheus Holdings (LNTH) United States $0.620B 19.29
NanoString Technologies (NSTG) United States $0.520B 0.00
Evolus (EOLS) United States $0.507B 0.00
Quanterix (QTRX) United States $0.445B 0.00
Cytosorbents (CTSO) United States $0.415B 0.00
Utah Medical Products (UTMD) United States $0.355B 22.87
Surface Oncology (SURF) United States $0.334B 0.00
BioLife Solutions (BLFS) United States $0.290B 0.00
Bovie Medical (BVX) United States $0.239B 0.00
Rockwell Medical (RMTI) United States $0.226B 0.00
Chimerix (CMRX) United States $0.188B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.167B 0.00
Fonar (FONR) United States $0.156B 7.76
Chembio Diagnostics (CEMI) United States $0.130B 0.00
Female Health (VERU) United States $0.101B 0.00
Trinity Biotech (TRIB) Ireland $0.086B 25.81
Oramed Pharmaceuticals (ORMP) Israel $0.084B 0.00
United-Guardian (UG) United States $0.076B 16.72
Neurotrope (NTRP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.059B 0.00
CAS Medical Systems (CASM) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.045B 0.00
Capricor Therapeutics (CAPR) United States $0.034B 0.00
Myomo (MYO) United States $0.028B 0.00
Valeritas Holdings (VLRX) United States $0.025B 0.00
Akers Biosciences Inc (AKER) United States $0.023B 0.00
Senestech (SNES) United States $0.017B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.010B 0.00